A phase I/II study of atezolizumab in pediatric and young adult patients with refractory/relapsed solid tumors (iMATRIX-Atezolizumab).
暂无分享,去创建一个
M. Kowgier | B. Geoerger | A. Kwan | S. DuBois | M. Casanova | L. Marshall | T. Trippett | Erin E. Karski | M. Tagen | M. Zwaan | Meghna Das-Thakur